91
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Apathy in patients with Parkinson’s disease

Pages 298-306 | Published online: 11 Jul 2009

References

  • AMERICAN PSYCHIATRIC ASSOCIATION (1994). Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC: American Psychiatric Association.
  • ANDREASEN, N.C. (1982). Negative symptoms in schizophrenia. Archives of General Psychiatry, 39, 784-788.
  • BECHARA, A., TRANEL, D., DAMASIO, H. & DAMASIO, A.R. (1996). Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex. Cerebral Cortex, 6, 215-225.
  • BENJAMIN, J., LI, L., PATTERSON, C., GREENBERG, B.D., MURPHY, D.L. & HAMER, D.H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genetics, 12, 81-84.
  • BERLIN, R.M., LITOVITZ, G.L., DIAZ, M. & AHMED, S.W. (1984). Sleep disorders on a psychiatric consultation service. American Jour nal of Psychiatr y, 141, 582-584.
  • CAMPBELL, J.J. & DUFFY, J.D. (1997).Treatmentstrategies in amotivated patients. Psychiatric Annals, 27, 44-49.
  • CHIARELLO, R.J. & COLE, J.O. (1987).The use of psychos-timulants in general psychiatry: a reconsideration.Archives of General Psychiatry, 44, 286-295.
  • CLONINGER, C.R. (1987). A systematic method for clinical description and classi cation of personality variants: a proposal. Archives of General Psychiatry, 44, 573-588.
  • CLONINGER, C.R., PRZYBECK, T.R. & SVRAJUC, D.M. (1991). The tridimensional personality questionnaire: U.S. normative data. Psychological Reports, 69, 1047-1057.
  • COLE, S. & RAJU, M. (1996).Making the diagnosis of depression in the primary care setting. American Journal of Medicine, 101(Suppl 6A), 10S 17S.
  • COVINGTON, E.C. (1991). Depression and chronic fatigue in the patient with chronic pain. Primary Care, 18, 341-358.
  • CROW, T.J. (1972).A map of rat mesencephalon for electrical self-stimulation. B rain Research, 36, 265-273.
  • DARVILL, F.T. & WOOLEY, S. (1959). Double-blind evaluation of methylphenidate (Ritalin) hydrochloride: its use in the management of institutionalized geriatric patients. Jour nal of the American Medical Association, 169, 1739-1741.
  • DAVIDSON, R.J. (1999) Internet communication. Washing-tonpost.com Live online, 2 November.
  • DAVIDSON, R.J., ABERCROMBIE, H., NITSCHKE, J.B. & PUTNAM, K. (1999a). Regional brain function, emotion and disorders of emotion. Current Opinion in Neurobiology, 9, 228-34.
  • DAVIDSON, R.J., COE, C.C., DOLSKI, I. & DONZELLA, B. (1999b). Individual differences in prefrontal activation assymetry predict natural killer cell activity at rest and in response to challenge. B rain and Behaviour Immunology, 13, 93-108.
  • DUFFY, J.D. (1995). The neurology of alcoholic denial: implications for assessment and treatment. Canadian Journal of Psychiatry, 40, 257-263.
  • DUFFY, J.D. (1997). The neural substrates of motivation. Psychiatric Annals, 27, 24-29.
  • DUFFY, J.D. & KANT, R. (1997).Apathy secondary to neurologic disease. Psychiatric Annals, 27, 39-43.
  • EBSTEIN, R.P., NOVICK, O., UMANSKY, R., PRIEL, B., OSHER, Y., BLAINE, D., BENNETT, E.R., NEMANOV, L., KATZ, M. & BELMAKER, R.H. (1996).Dopamine D4 receptor(D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics, 12, 78-80.
  • ESTOUGH, V.M., KEMPSTER, P.A., STERN, G.M. & LEES, A.J. (1990). Premorbid personality and idiopathic Parkinson’s disease. In: M.B. STREIFLER, A.D. KORZYN, E. MELAMED & M.B. YOUDIM (Eds), Parkinson’s disease: anatomy, pathology, and therapy. Advances in Neurology (Vol. 53, pp. 335-337). NewYork: Raven Press.
  • FRAY, P., DUNNETT, S., IVERSEN, S., BJORKLAND, A. & STENEVI, U. (1983).Nigral transplants reinervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation. Science, 219, 416-419.
  • GERSTEN, S.P. (1980). Long term adverse effects of brief marijuana use. Journal of Clinical Psychiatry, 41, 60-61.
  • GOLD, M.S. & PEARSALL, H.R. (1983). Hypothyroidism or, is it depression? Psychosomatics, 24, 646-656.
  • HELGASON, C., WILBUR, A., WEISS, A., REDMOND, K.J. & KINGS-BURY, N.A. (1988). Acute pseudobulbar mutism due to discrete bilateral capsular infarction in the territory of the anterior choroidal artery. B rain, 111, 507-519.
  • HOLMES, F.P., KAPLAN, J.E., GANTZ, N.M., KOMAROFF, A.L., SCHONBERGER, L.B., STRAUS, S.E., JONES, J.F., DUBOIS, R.E., CUNNINGHAM-RUNDLES, C. & PAHWA, S. (1988). Chronic fatigue syndrome: a working case de nition. Annals of Internal Medicine, 108, 387-389.
  • HOOKS, M.S. & KALIVAS, P.W. (1994). Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. The Journal of Pharmacology and ExperimentalTherapeutics,269, 976-988.
  • JAFFE, G.V. (1961).Depression in general practice: a clinical trial of a new psychomotor stimulant. Practitioner, 186, 492-495.
  • JONSSON, E.G., NOTHEN, M.M., GUSTAVSSON, P., NEIDT, J., BRENE, S., TYLEC, A., PROPPING, P. & SEDVELL, G.C. (1997). Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. American Journal of Psychiatry, 154, 697-699.
  • KANT, R., DUFFY, J.D. & PIVOVARNIK, A. (1995). Apathy following closed head injury. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 425.
  • KATON, W., BERG, A., ROBINS, A.J. & AHMED, S.W. (1986) Depression: medical utilization and somatization. Western Journal of Medicine, 144, 564-568.
  • KAUFER, D.I., CUMMINGS, J.L. & CHRISTINE, D. (1996).Effect of tacrine on behavioral symptoms inAlzheimer’s disease: an open-label study. Journal of Geriatric Psychiatry and Neurology, 9, 1-6.
  • KRUPP, B.H., (1997). Ethical considerations in apathy syndromes. Psychiatric Annals, 27, 50-54.
  • KRUPP, B.H. & FOGEL, B.S. (1997). Motivational impairment in primary psychiatric and medical illness. Psychiatric Annals, 27, 34-38.
  • LEVY, M.L., MILLER, B.L., CUMMINGS, J.L., FAIRBANKS, L.A. & CRAIG, A. (1996). Alzheimer’s disease and frontotem-poral dementias: behavioral distinctions. Archives of Neurology, 53, 687-690.
  • LEVY, M.L., CUMMINGS, J.L., FAIRBANKS, L.A., MASTERMAN, D., MILLER, B.L., CRAIG, A.H., PAULSEN, J.S. & LITVAN, I. (1998). Apathy is not depression. Journal of Neuropsy-chiatry and Clinical Neurosciences, 10, 314-319.
  • LITVAN, I., MEGA, M.S., CUMMINGS, J.L. & FAIRBANKS, L. (1996).Neuropsychiatric aspects of progressive supranu-clear palsy. Neurology, 47, 1184-1189.
  • MARIN, R.S. (1990). Differential diagnosis and classi cation of apathy.American Journal of Psychiatry,147, 22-30.
  • MARIN, R.S. (1991).Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 243-254.
  • MARIN, R.S. (1997). Differential diagnosis of apathy and related disorders of diminished motivation. Psychiatric Annals, 27, 30-33.
  • MARIN, R.S., BIEDRZYCKI, R.C. & FIRINCIOGULLARI, S. (1991). Reliability and validity of the apathy evaluation scale. Psychiatry Research, 38, 143-162.
  • MARIN, R.S., FIRINCIOGULLARI, S. & BIEDRZYCKI, R.C. (1994). Differences in the relationship between apathy and depression. Jour nal of Nervous Mental Disorders, 182, 235-239.
  • MARIN, R.S., FOGEL, B.S., HAWKINS, J., DUFFY, J. & KRUPP, B. (1995). Apathy: a treatable syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 23-30.
  • MARSDEN, C.D. & PARKES, J.D. (1977).Success and problems of long-term levodopa therapy in Parkinson’s disease. Lancet, 1, 345-349.
  • MASAND, P.S. & TESAR, G.E. (1996). Use of stimulants in medically ill. Psychiatric Clinics of North America, 19, 515-547.
  • MAYEUX, R., STERN, Y., SANO, M., COTE, L. & WILLIAMS, J.B. (1987). Clinical and biochemical correlates of brady-phrenia in Parkinsons disease. Neurology, 37, 1130-1134.
  • MENZA, M.A., FORMAN, N.E., GOLDSTEIN, H.S. & GOLBE, L.I. (1990). Parkinson’s disease, personality and dopamine. Journal of Neuropsychiatry and Clinical Neuro-sciences, 2, 282-287.
  • MENZA, M.A., GOLBE, L.I., CODY, R.A. & FORMAN, N.E. (1993). Dopamine-related personality traits in Parkinson’s disease. Neurology, 43, 505-508.
  • NAVIA, B.A., JORDAN, B.D. & PRICE, R.N. (1986).The AIDS-dementia complex I:clinical features.Annals of Neurology, 19, 517-524.
  • OTT, B.R., NOTO, R.B. & FOGEL, B.S. (1996). Apathy and loss of insight in Alzheimer’s disease: a SPECT imaging study. Journal of Neuropsychiatry and Clinical Neuro-sciences, 8, 41-46.
  • PEREZ-ESTABLE, E.J., MIRANDA, J., MUNOZ, R.F. & YING, Y.W. (1990). Depression in medical outpatients. Archives of Internal Medicine, 150, 1083-1088.
  • PERRY, T.L., WRIGHT, J.M., BERRY, K., HANSEN, S. & PERRY, T.L. (1990).Dominantly inherited apathy, central hypov-entilation, and Parkinson’s syndrome: clinical, biochemical, and neuropatholgic studies of 2 new cases. Neurology, 40, 1882-1887.
  • POEWE, W., KARAMAT, E., KEMMLER, G.W. & GERSTENBRAND, F. (1990). The premorbid personality of patients with Parkinson’s disease: a comparative study with healthy controls and patients with essential tremor. In: M.B. STREIFLER, A.D. KORZYN, E. MELAMED & M.B. YOUDIM (Eds), Parkinson’s disease: anatomy, pathology, and therapy. Advances in Neurology (Vol. 53, pp. 339-342). NewYork: Raven Press.
  • SALLOWAY, S., MALLOY, P.F., KOHN, R., GILLARD, E., DUFFY, J., ROGG, J., TUNG, G., RICHARDSON, E., THOMAS, C. & WESTLAKE, R. (1996).MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology, 46, 1567-1574.
  • SCHULBERG, H.C., SAUL, M. & MCLELLAND, M. (1985). Assessing depression in primary medical and psychiatric practices. Archives of General Psychiatr y, 12, 1164-1170.
  • SHULMAN, L.M., LEIFERT, R., SINGER, C. & WEINER, W.J. (1997). The diagnostic accuracy of neurologists for anxiety, depression, fatigue and sleep disorders in Parkinson’s disease. Movement Disorders, 12(Suppl 1), 127.
  • SHULMAN, L.M., SINGER, C., LEIFERT, R., MELLMAN, T.A. & WEINER, W.J. (1996).The comorbidity of the nonmotor symptoms of Parkinson’s disease. Annals of Neurology, 40, 536.
  • SILVA, S.J. & MARIN, R.S. (1995). Apathy in neuropsychi-atric disorders. CNS Spectrums, 4, 31-50.
  • SIMON, G.E. & VON KORFF, M. (1995).Recognition, manage-ment, and outcomes of depression in primary care. Archives of Family Medicine, 4, 99-105.
  • STARKMAN, M.N. & SCHTEINGART, D.E. (1981). Neuropsy-chiatric manifestations of patients with Cushing’s syndrome. Archives of Internal Medicine, 141, 215-219.
  • STARKSTEIN, S.E., FEDEROFF, J.P., PRICE, T.R., LEIGUARDA, R. & ROBINSON, R.G. (1993). Apathy following cerebrovas-cular lesions. Stroke, 24, 1625-1630.
  • STARKSTEIN, S.E., MAYBERG, H.S., PREZIOSI, T.J., ANDREZE-JEWSKI, P., LEIGUARDA, R. & ROBINSON, R.G. (1992). Reliability, validity and clinical correlates of apathy in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 134-139.
  • STELLAR, J.R. & STELLAR, E. (1985). The neurobiology of motivation and reward. NewYork: Springer.
  • SULLIVAN, P.F., FIFIELD, W.J., KENNEDY, M.A., MULDER, R.T., SELLMAN, J.D. & JOYCE, P.R. (1998). No association between Novelty Seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. American Journal of Psychiatry, 155, 98-101.
  • SZEGEDI, A., HILBERT, A., WETZEL, H., KLIESER, E., GAEBEL, W. & BENKERT, O. (1997). Pramipexole, a dopaminergic agonist in major depression: antidepressant effects and tolerability in an open label study with multiple doses. Clinical Neuropharmacology, 20, S36 S45.
  • TODES, C.J. & LEES, A.J. (1985).The pre-morbid personality of patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 48, 97-100.
  • VALLERAND, R.J., O’CONNOR, B.P. & HAMEL, M. (1995). Motivation in later life: theory and assessment. International Journal of Aging and Human Development, 41, 221-238.
  • VARADARAJ, R. & COOPER, A.J. (1986). Addison’s disease presenting with psychiatric symptoms. American Journal of Psychiatry, 143, 553-554.
  • WEBSTER, J. & GROSSBERG, G. (1996). Disinhibition, apathy, indifference, fatigability, complaining and negativism. International Psychogeriatrics, 8(Suppl 3), 403-408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.